Aphton Corporation
Oncology company reports loss of $0.21 per share
Published in Health Business Week, September 2nd, 2005
The company ended the second quarter with cash, cash equivalents and short-term investments of $27.3 million.
"Based on the progress made in the first half of the year, we believe that Aphton is in a stronger position in terms of our pipeline, our finances and our operations," commented Patrick Mooney, MD, chairman and CEO of Aphton Corporation. "We have cut our going-forward burn rate by almost 50% this year without sacrificing our priority programs and we are continuing to evaluate further steps that could conserve even more capital as we move...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2005-09-02)
More Articles from Health Business Week
- Accellent Corp.
Medical device firms report 90% increase in sales - Adeza
Women's health product maker reports 27% increase in sales - Aethlon Medical, Inc.
Medical device maker appoints James W. Dorst as chief financial officer - Applied Imaging Corp.
Medical device firm records $0.09 per share loss - ArthroCare Corp.
Medical device firm reports revenues of $51.7M - Avant Immunotherapeutics, Inc.
Vaccine developer reports loss of $0.06 per share - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
